CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 215712-215935 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T59127","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our results demonstrate a sequential modulation of mRNA expression during the acute phase of GNDF ( Pb0.05) and NT-3 ( Pb0.01), and a persisting overexpression of NT-3 mRNA even 2 months after acute encephalitis ( Pb0.001)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T158","span":{"begin":0,"end":223},"obj":"Sentence"}],"text":"Our results demonstrate a sequential modulation of mRNA expression during the acute phase of GNDF ( Pb0.05) and NT-3 ( Pb0.01), and a persisting overexpression of NT-3 mRNA even 2 months after acute encephalitis ( Pb0.001)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T341","span":{"begin":199,"end":211},"obj":"Phenotype"}],"attributes":[{"id":"A341","pred":"hp_id","subj":"T341","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Our results demonstrate a sequential modulation of mRNA expression during the acute phase of GNDF ( Pb0.05) and NT-3 ( Pb0.01), and a persisting overexpression of NT-3 mRNA even 2 months after acute encephalitis ( Pb0.001)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1113","span":{"begin":199,"end":211},"obj":"Disease"},{"id":"T19213","span":{"begin":199,"end":211},"obj":"Disease"}],"attributes":[{"id":"A1113","pred":"mondo_id","subj":"T1113","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A73011","pred":"mondo_id","subj":"T19213","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"}],"text":"Our results demonstrate a sequential modulation of mRNA expression during the acute phase of GNDF ( Pb0.05) and NT-3 ( Pb0.01), and a persisting overexpression of NT-3 mRNA even 2 months after acute encephalitis ( Pb0.001)."}